ArthNow Logo
ArthNow
•2 min read•
✦Reported by cnbctv18

RateGain retains FY27 revenue guidance, targets $1 billion revenue by FY31

RateGain retains FY27 revenue guidance, targets $1 billion revenue by FY31
Source: cnbctv18

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓RateGain Travel Technologies retained its FY27 revenue guidance of ₹3,100 crore despite global uncertainties.
  • ✓The company targets $1 billion revenue by FY31 through organic growth and acquisitions.
  • ✓Founder Bhanu Chopra said, "We will continue to stick to the guidance that we have provided." It remains focused on North America and Europe.

Story at a Glance

Category
Indian Markets
Reported By
cnbctv18
Reading Speed
2 Minute(s)
Market Focus
India Economy

RateGain plans to achieve its $1 billion revenue target by FY31 through 15% organic growth and acquisitions, supported by a stronger balance sheet, healthy cash generation and an active M&A pipeline focused on North America and Europe.

Noida-based RateGain Travel Technologies has retained its financial year 2026-27 (FY27) revenue guidance of ₹3,100 crore despite global uncertainties. The company expects stronger growth in the second half while continuing to pursue acquisitions to achieve its long-term target of $1 billion in revenue by 2030-31 (FY31).

The acquisition pipeline remains active and its balance sheet is well-positioned to support future deals, said Founder and Chairman Bhanu Chopra.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

cnbctv18

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.